Skip to main content
Nutrition & Metabolism logoLink to Nutrition & Metabolism
. 2015 Jul 30;12:25. doi: 10.1186/s12986-015-0021-6

Consumption of sugar sweetened beverage is associated with incidence of metabolic syndrome in Tehranian children and adolescents

Parvin Mirmiran 1,, Emad Yuzbashian 1, Golaleh Asghari 1, Somayeh Hosseinpour-Niazi 1, Fereidoun Azizi 2
PMCID: PMC4518610  PMID: 26225136

Abstract

Background

Intakes of high sugar-sweetened beverages (SSBs) in adults can escalate risk of metabolic syndrome (MetS); however, data of longitudinal studies in children and adolescents are lacking. In this study we assessed consumption of SSBs in relation to incidence of MetS among children and adolescents during a 3.6 year follow-up.

Methods

This study was a population-based longitudinal study, in which 424 subjects, aged 6–18 years, from the Tehran Lipid and Glucose Study with complete data on dietary intake, blood pressure, anthropometry, and biochemical indices were followed for 3.6 years. Dietary intake was collected using a valid and reliable food frequency questionnaire. MetS was defined according to the Cook criteria. Sugar sweetened beverages included all kinds of sugar sweetened carbonated soft drinks (SSSDs) and fruit juice drinks.

Results

Average daily intakes of SSSD and fruit juice drinks were 38.5 ± 75.0 and 32.3 ± 60.1 g, respectively. After adjustment for confounders, compared to the first quartile, the odds ratio of incident MetS in the highest quartile of SSB and SSSD was 3.20 (95 % CI: 1.06–9.90) and 3.01 (95 % CI: 1.17–7.74), respectively. Regarding incidence of MetS components, compared with the lowest quartile, the highest quartile of SSSDs showed odds ratios of 2.49 (95 % CI: 1.00–6.53) for abdominal obesity and 2.79 (95 % CI: 1.02–7.64) for hypertension. No significant association was found between consumption of fruit juice drink and SSSD with other components of MetS.

Conclusions

Children and adolescents with high intakes of carbonated beverages could be at increased risk of MetS, abdominal obesity, and hypertension.

Keywords: Metabolic syndrome, Children, Adolescents, Sugar sweetened carbonated soft drink, Fruit juice drink, Sugar sweetened beverage

Introduction

The rising prevalence of metabolic syndrome (MetS) during childhood and adolescence affectes over 3.3 % of the adolescent population worldwide [1], and may be predictive of adult MetS, type 2 diabetes, and cardiovascular disease [2, 3]. Although some studies have examined genetic predispositions, findings show that only 10 % of MetS cases can be explained by genetics [4]. Alternatively, many environmental factors have been identified [5], e.g. food intakes play an important role in the pathogenesis of MetS through hepatic insulin resistance and/or increasing reactive oxygen species formation [6].

Nowadays the consumption of sugar sweetened beverages (SSBs) has increased drastically particularly in children and adolescents [79]. Higher SSB intakes in adults may enhance risk of weight gain and of developing obesity and obesity-related disorders, such as MetS, type 2 diabetes, coronary heart disease, and stroke [10, 11]. However, according to a recent evidence mapping study by Althuis et al. [12], longitudinal studies in children and adolescents are lacking and limited to one cross-sectional investigation, which indicated that SSBs have been linked to increased risk of MetS, hypertension, and abdominal obesity [13].

In the current study, we evaluated the association between SSB consumption with incident MetS and its components 3.6 years later among children and adolescents in Iran.

Materials and method

Tehran Lipid and Glucose Study (TLGS) is a prospective community-based study being conducted to determine the risk factors of and prevent non-communicable diseases by implementing and promoting healthy lifestyles [14].

Baseline data were collected from 15005 participants, aged 3 years and over, of residents District No. 13 of Tehran under coverage of three medical health centers. The participants were followed up every 3 years to update their data on demographic, lifestyle, biochemical, clinical, and dietary measurements; the baseline survey was a cross-sectional study conducted from 1999 to 2001, and surveys 2 (2002–2005), 3 (2006–2008), and 4 (2009–2011) were prospective follow-up surveys.

In the third survey of the TLGS (2006–2008), from among 12523 examined participants, 3462 were randomly selected for dietary assessment; of these, 621 individuals were aged 6–18 y who included in the current study. Participants who had incomplete dietary intakes or had missing measures of MetS components (n = 29) were excluded. Additionally, participants with reported energy intakes (kcal/day) to energy requirements ratios beyond ±3SD range, were also excluded (n = 6) because they fell into the over-or under-reporting categories [15]. Participants were followed until survey 4 (2009–2011), an average of 3.6 years (follow-up rate: 86 %). Depending on the outcome variable under analysis, we excluded persons whose data at survey 3 (2006–2008) indicated prevalent MetS (n = 69), hypertension (n = 53), high triglycerides (TGs) (n = 168), low high density lipoprotein cholesterol (HDL-C) (n = 242), high fasting plasma glucose (FPG) (n = 12), or abdominal obesity (n = 145); some individuals fell into more than one exclusion category. The final sample sizes in fully adjusted models varied by outcomes as follows: MetS (n = 424), abdominal obesity (n = 327), high triglycerides (TGs) (n = 347), hypertension (n = 439), low HDL-C (n = 290), and high fasting plasma glucose (n = 476).

The design of this study was approved by the institutional ethics committee of the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, and written informed consent was obtained from participants’ parents.

Dietary intake

A valid and reliable 168-item semi-quantitative food frequency questionnaire (FFQ) [1618] was used by trained dietitians, during face-to face interviews, to evaluate the usual dietary intakes of participants. Participants were asked to report their consumption frequency of food items during the previous year on a daily, weekly, or monthly basis. Mothers were asked about the type and quantity of meals and snacks when children were unable to recall. Portion sizes of consumed foods were specified according to the US Department of Agriculture (USDA) standard portion sizes or household measures (e.g. beans, 1 tablespoon; chicken meat, 1 leg or wing; rice, 1 large or small plate) [19]. Obtained data were converted to mean daily intake in grams or milliliters. This FFQ included questions on the frequency of consumption and usual portion size of all kinds of sugar sweetened carbonated soft drinks (SSSDs) and fruit juice drinks (both 100 % fruit juice and sugar sweetened synthetic juice drinks that are not 100 % juice). According to Althuis et al. [12], these items were combined to estimate the daily intake of SSBs (ml/d). SSB intakes were divided by using quartile cutoffs, with the assumption that one serving was equivalent to 1 cup (250 mL).

To study the reproducibility of the FFQ, 132 subjects (61 men and 71 women) twice completed a 168-item FFQ (FFQ1, FFQ2), with a 14-month interval between FFQ1 and FFQ2, and to assess the validity, 12 dietary recalls (DRs) were collected (1 each month) over the 1-year interval. The age-and energy-adjusted and deattenuated Spearman correlation coefficients used to assess validity of the FFQ for soft drinks were 0.54 and 0.37 in men and women, respectively. The age-and energy-adjusted intraclass correlation coefficients, which reflect the reproducibility of food groups in the FFQ, were 0.61 and 0.65 in men and in women, respectively [17].

Measurements

Information about physical activity was collected using the modifiable activity questionnaire (MAQ) to calculate metabolic equivalent task (MET) minutes per week [20]. High reliability (98 %) and moderate validity (47 %) were ascertained for the MAQ translated into Persian [21]. Levels of physical activity were categorized as light (MET <600 min/wk), moderate (MET 600–1,499 min/wk), and vigorous (MET ≥1,500 min/wk).

Weight was measured, while participants were minimally clothed without shoes, using digital scales (Seca 707, Seca Corp., Hanover, MD; range 0.1–150 kg) and recorded to the nearest 100 g. Height was measured in a standing position without shoes, using a stadiometer, with shoulders in normal alignment. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m2). Waist circumference (WC) was measured at the umbilicus, using a measuring tape, without pressure to body surfaces, and was recorded to the nearest 0.5 cm.

Blood pressure was measured twice, after participants were seated for 15 min, using a standard mercury sphygmomanometer; there was at least a 30-s interval between these two separate measurements, and the mean of two measurements was considered the patient’s blood pressure.

Blood samples, at baseline and follow up, were drawn between 7:00 and 9:00 AM from all study participants after 12–14 h overnight fasting; all blood analyses were done at the TLGS research laboratory on the day of blood collection. FPG was measured by the enzymatic colorimetric method using glucose oxidase. Serum HDL-C was measured after precipitation of the apolipoprotein B-containing lipoproteins with phosphotungstic acid and serum TGs were assayed using an enzymatic colorimetric method with glycerol phosphate oxidase. These analyses were performed using commercial kits (Pars Azmoon Inc., Tehran, Iran) and a Selectra 2 auto analyzer (Vital Scientific, Spankeren, The Netherlands). Inter-and intra-assay coefficients of variations at baseline were both 2.2 % for FPG, 2 and 0.5 % for HDL-C and 1.6 and 0.6 % for TGs, respectively.

Definitions

In children and adolescents, MetS was defined according to definition proposed by Cook et al. as 3 or more of the following [22]: Fasting TGs ≥110 mg/dl; HDL-C < 40 mg/dl; WC ≥ 90th percentile for age and sex, according to national reference curves [23]; systolic blood pressure and diastolic blood pressure ≥90th percentile for sex, age and height, from the National Heart, Lung, and Blood Institute’s recommended cut-off points [24], and FPG ≥ 100 mg/dl, according to the recommendations of American Diabetes Association [25]. In subjects aged > 18 years after follow-up, MetS was defined according to the joint interim statement [26] as the presence of any 3 of 5 risk factors of the following: 1) Abdominal obesity as WC ≥91 and men ≥89 cm for women and men, respectively, according to Iranians cut-off points [27]; 2) FPG ≥100 mg/dl or drug treatment; 3) fasting TGs ≥150 mg/dl or drug treatment; 4) fasting HDL-C <50 mg/dl for women and <40 mg/dl for men or drug treatment, and 5) hypertension was defined as systolic blood pressure ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or antihypertensive drug treatment.

Statistical analysis

All analyses were conducted using the Statistical Package for Social Sciences (version 15.0; SPSS Inc, Chicago IL). Baseline characteristics of subjects were expressed as mean ± SD or median (interquartile 25–75) for continuous variables and percentages for categorical variables. To investigate the trend of continuous and categorical variables according to quartiles of SSB, linear regression and chi-square test were used, respectively. There were no significant differences in baseline anthropometric and biochemical assessments between subjects who provided follow-up assessments and those lost to follow-up (data not shown).

Intakes of SSBs (<19.2, 19.2-43.8, 43.9-91.5, and >91.6 ml/day), SSSDs (<7.6, 7.6–15.3, 15.3–40.0, and >40.0 ml/day), and fruit juice drinks (<4.1, 4.1–13.5, 13.5–34.9, and 34.9 ml/day) were categorized into the quartile cut off points. To estimate the risk of 3.6-year incident outcomes, separate multiple regression models were used for abdominal obesity, high FPG, high TGs, low HDL-C, hypertension, and MetS with quartiles of SSB, SSSD, and fruit juice drink consumption; odds ratios (OR) and 95 % confidence interval (CI) were reported. The initial model was adjusted for age, sex, total energy intake, physical activity, and family history of diabetes. Further adjustment for dietary fiber, tea and coffee, red and processed meat, fruits, and vegetables was made and the final model was additionally adjusted for BMI.

Results

The mean ± SD age of study population (68 % girls) was 13.6 ± 3.7 years; the mean daily SSB intake was 98 ml in boys and 70 ml in girls. After a 3.6 year follow up, cumulative incidence of MetS was 11 %.

The descriptive characteristics of the study population according to quartile of SSB consumption are shown in Table 1. Participants with higher SSB consumption were likely to have higher systolic blood pressure, FPG, and BMI; in addition, subjects with higher SSB consumption had higher intakes of daily energy, saturated fatty acids, trans-fatty acids, glucose, fructose, sucrose, simple sugars, higher glycemic index, and lower intakes of fruits and whole grains.

Table 1.

Baseline characteristics of children and adolescents according to quartiles of sugar sweetened beverage consumption: Tehran Lipid and Glucose Study

Quartiles P for trend1
Q1 (n = 106) Q2 (n = 106) Q3 (n = 106) Q4 (n = 106)
Median intake (ml/d) 9.3 32.0 58.6 142.2
Age (years) 13.8 ± 3.7 12.9 ± 3.7 13.8 ± 3.7 13.7 ± 3.6 0.737
Girls (%) 72 43 62 50 0.092
Systolic blood pressure (mmHg) 96.8 ± 12.2 97.7 ± 10.7 97.1 ± 11.7 100.2 ± 12.0 0.021
Diastolic blood pressure (mmHg) 64.3 ± 9.4 63.9 ± 6.9 65.7 ± 9.1 64.7 ± 10.2 0.520
Triglycerides (mg/dl) 83.0 (62.7–103.2) 77.0 (63.0–94.0) 84.0 (64.0–105.2) 81.5 (63.0–112.5) 0.216
Fasting plasma glucose (mg/dl) 83.9 ± 5.9 84.4 ± 5.9 85.5 ± 5.8 86.0 ± 6.5 0.037
High density lipoprotein (mg/dl) 45.8 ± 11.9 46.3 ± 11.11 47.3 ± 9.6 43.8 ± 9.4.2 0.269
Waist circumstance (cm) 69.7 ± 11.1 69.7 ± 10.4 67.8 ± 10.6 68.1 ± 9.5 0.231
Body mass index (kg/m2) 18.7 ± 4.3 19.2 ± 3.8 19.7 ± 3.6 20.1 ± 3.8 <0.001
Daily dietary intakes
 Total energy (kcal) 2116 ± 962 2364 ± 1017 2440 ± 1020 3317 ± 1670 <0.001
 Dietary fiber/1000 kcal (g) 14.5 ± 6.4 14.4 ± 6.6 14.6 ± 5.5 14.2 ± 4.6 0.866
 Total fat (% energy) 32.4 ± 8.5 31.9 ± 6.3 32.3 ± 7.2 31.6 ± 5.5 0.785
 Trans-fatty acids (g) 4.17 ± 3.88 4.23 ± 2.83 5.26 ± 5.77 6.6 ± 4.6 <0.001
 Saturated fatty acids (g) 25.1 ± 12.7 28.1 ± 13.2 27.6 ± 16.4 41.9 ± 23.2 <0.001
 Protein (% energy) 13.0 ± 2.4 13.8 ± 3.4 12.8 ± 1.9 12.9 ± 1.9 0.230
 Carbohydrate (% energy) 56.2 ± 8.7 56.8 ± 7.4 57.1 ± 7.1 57.5 ± 5.9 0.098
 Glucose (g) 11.7 ± 7.8 14.7 ± 7.5 15.2 ± 7.2 25.2 ± 15.2 <0.001
 Fructose (g) 13.2 ± 8.8 16.5 ± 8.2 18.2 ± 8.7 23.9 ± 7.9 <0.001
 Sucrose (g) 26.8 ± 21.2 30.6 ± 20.3 36.5 ± 60.4 41.1 ± 28.4 <0.001
 Total simple sugar (g) 111.4 ± 81.8 118.7 ± 56.0 124.3 ± 81.9 142.9 ± 98.0 <0.001
 Total simple sugar (% energy) 20.8 ± 7.7 20.3 ± 5.2 20.2 ± 5.76 21.6 ± 5.7 0.422
 Glycemic index 61.1 ± 35.8 78.4 ± 38.2 81.5 ± 45.11 102.1 ± 74.5 <0.001
 Fruit (g/1000 kcal) 183.4 ± 118 173.5 ± 113.6 160.5 ± 94.4 130.4 ± 100.1 <0.001
 Vegetable (g/1000 kcal) 105.7 ± 66.2 94.8 ± 55.8 97.4 ± 53.5 94.5 ± 46.2 0.200
 Low fat dairy (g/1000 kcal) 117.9 ± 90.3 113.9 ± 89.7 109.1 ± 75.3 121.5 ± 91.9 0.875
 Meat and processed meat (g/1000 kcal) 11.4 ± 11.9 12.9 ± 9.4 12.5 ± 10.1 14.9 ± 11.2 0.076
 Legumes (g/1000 kcal) 7.0 ± 8.9 6.9 ± 7.6 7.3 ± 9.1 5.9 ± 7.1 0.362
 Whole grains (g/1000 kcal) 38.7 ± 40.9 30.9 ± 31.6 27.0 ± 25.0 26.5 ± 26.6 0.003

Data represented as mean ± SD or median (IQ 25–75) for continuous variables and percentage for categorically distributed variables

1Based on linear regression models for continuous variables and chi-square for categorical variables

Sugar sweetened beverage intake was inversely related to MetS and its components after adjustment for potential confounders (Table 2). Further adjustment for dietary factors did not have a major impact on the results. In this model, subjects in the highest quartile of SSB consumption had increased risk of incident MetS (OR: 3.16; 95 % CI: 1.02–9.78, P for trend = 0.007) and abdominal obesity (OR: 2.97; 95 % CI: 1.23–7.19, P for trend = 0.017). Adjustment for BMI slightly strengthened the association; adjusted multivariable ORs of MetS, abdominal obesity, and hypertension were 3.50, 3.66, and 2.90 (all P for trends < 0.05).

Table 2.

Multivariable-adjusted ORs (95 % CIs) of incident MetS and its components by quartiles of sugar sweetened beverage consumption after 3.6 years of follow up among children and adolescents

Quartiles P for trend1
Q1 Q2 Q3 Q4
Median intake (ml/d) 9.3 32.0 58.6 142.2
MetS
 Model 1 1.00 1.06 (0.31–3.57) 2.84 (0.97–8.37) 3.00 (0.99–9.05) 0.009
 Model 2 1.00 1.02 (0.30–3.48) 2.94 (0.99–8.74) 3.16 (1.02–9.78) 0.007
 Model 3 1.00 1.11 (0.32–3.82) 2.96 (0.99–8.80) 3.50 (1.12–10.92) 0.005
Low HDL-C
 Model 1 1.00 0.72 (0.24–2.16) 0.96 (0.33–2.82) 0.55 (0.17–1.81) 0.434
 Model 2 1.00 0.61 (0.19–1.89) 0.93 (0.31–2.78) 0.42 (0.11–1.55) 0.320
 Model 3 1.00 0.65 (0.21–2.07) 0.97 (0.32–2.93) 0.45 (0.12–1.66) 0.386
Abdominal obesity
 Model 1 1.00 1.53 (0.63–3.71) 1.65 (0.61–3.94) 2.94 (1.27–6.82) 0.012
 Model 2 1.00 1.58 (0.65–3.86) 1.70 (0.70–4.09) 2.97 (1.23–7.19) 0.017
 Model 3 1.00 2.16 (0.82–5.68) 1.86 (0.71–4.84) 3.66 (1.40–9.59) 0.016
Hypertension
 Model 1 1.00 1.46 (0.45–4.77) 2.66 (0.89–7.96) 2.41 (0.79–7.73) 0.070
 Model 2 1.00 1.47 (0.45–4.82) 2.68 (0.89–8.11) 2.45 (0.78–7.70) 0.072
 Model 3 1.00 1.73 (0.52–5.74) 3.02 (0.98–9.25) 2.90 (0.91–9.26) 0.043
High FPG
 Model 1 1.00 1.22 (0.56–3.22) 1.90 (0.76–4.72) 2.07 (0.79–5.39) 0.079
 Model 2 1.00 1.17 (0.44–3.08) 1.83 (0.73–4.58) 1.90 (0.71–5.09) 0.109
 Model 3 1.00 1.21 (0.48–3.21) 1.87 (0.75–4.68) 1.95 (0.73–5.22) 0.108
High TGs
 Model 1 1.00 0.76 (0.24–2.38) 1.57 (0.57–4.33) 1.70 (0.58–4.99) 0.156
 Model 2 1.00 0.74 (0.23–2.33) 1.53 (0.55–4.29) 1.66 (0.55–5.05) 0.173
 Model 3 1.00 0.82 (0.26–2.61) 1.62 (0.57–4.58) 1.80 (0.59–5.25) 0.148

MetS metabolic syndrome, HDL-C high density lipoprotein-cholesterol, FPG fasting plasma glucose, TGs triglycerides

Model1: Adjusted for baseline age, sex, total energy intake, physical activity, and family history of diabetes

Model 2: Additionally adjusted for dietary fiber, tea and coffee, red and processed meat, fruit, and vegetable

Model 3: Additionally adjusted for body mass index

1Based on logistic regression model using median intake of sugar sweetened beverages in each quartile as a continuous variable

Higher intakes of SSSD was associated with significant increase in the risk of incident MetS (OR: 3.58, 95 % CI: 1.09-11.78, P for trend = 0.013), abdominal obesity (OR: 3.78, 95 % CI: 1.08–13.27, P for trend = 0.043), and hypertension (OR: 2.74, 95 % CI: 1.05–7.19, P for trend = 0.018) in the fully adjusted model. Associations for fruit juice drink intake were not statistically significant (Table 3).

Table 3.

Multivariable-adjusted ORs (95 % CIs) of incident MetS and its components by quartiles of sugar sweetened carbonated soft drink and fruit juice drink intakes after 3.6 years of follow up among children and adolescents

Quartiles P for trend1
Q1 Q2 Q3 Q4
Sugar sweetened carbonated soft drink (ml/d) 1.12 9.33 33.06 100.00
MetS
 Model 1 1.00 1.06 (0.31–3.57) 2.29 (0.76–6.97) 3.33 (1.04–10.73) 0.014
 Model 2 1.00 1.02 (0.30–3.47) 2.39 (0.78–7.31) 3.45 (1.06–11.18) 0.012
 Model 3 1.00 1.11 (0.32–3.82) 2.44 (0.79–7.49) 3.58 (1.09–11.78) 0.013
Low HDL-C
 Model 1 1.00 0.38 (0.12–1.30) 0.77 (0.31–1.93) 1.00 (0.33–2.98) 0.982
 Model 2 1.00 0.37 (0.11–1.27) 0.71 (0.28–1.84) 1.15 (0.35–3.79) 0.950
 Model 3 1.00 0.37 (0.11–1.28) 0.69 (0.26–1.80) 1.15 (0.35–3.81) 0.989
Abdominal obesity
 Model 1 1.00 1.73 (0.72–4.16) 1.99 (0.83–4.77) 2.76 (0.92–8.28) 0.064
 Model 2 1.00 1.85 (0.76–4.49) 2.23 (0.91–5.43) 3.39 (1.08–10.70) 0.034
 Model 3 1.00 1.57 (0.60–4.06) 2.03 (0.78–5.28) 3.78 (1.08–13.27) 0.043
Hypertension
 Model 1 1.00 0.77 (0.25–2.36) 1.29 (0.46–3.57) 2.64 (1.03–6.80) 0.022
 Model 2 1.00 0.80 (0.26–2.44) 1.36 (0.48–3.84) 2.84 (1.04–7.19) 0.021
 Model 3 1.00 0.79 (0.26–2.44) 1.37 (0.49–3.84) 2.74 (1.05–7.19) 0.018
High FPG
 Model 1 1.00 0.58 (0.21–1.60) 1.97 (0.86–4.53) 1.12 (0.41–3.10) 0.243
 Model 2 1.00 0.56 (0.20–1.56) 1.95 (0.84–4.54) 1.11 (0.40–3.11) 0.255
 Model 3 1.00 0.55 (0.20–1.54) 1.93 (0.83–4.50) 1.12 (0.40–3.12) 0.251
High TGs
 Model 1 1.00 1.04 (0.35–3.11) 2.01 (0.71–5.68) 1.89 (0.65–5.60) 0.137
 Model 2 1.00 1.03 (0.34–3.12) 2.04 (0.71–5.89) 1.97 (0.46–6.02) 0.124
 Model 3 1.00 0.83 (0.27–2.58) 1.91 (0.66–5.50) 1.75 (0.57–5.37) 0.148
Fruit juice drink (ml/d) 1.31 8.29 20.40 67.14
MetS
 Model 1 1.00 1.17 (0.46–2.96) 0.62 (0.22–1.79) 1.18 (0.46–3.06) 0.993
 Model 2 1.00 1.10 (0.42–2.82) 0.60 (0.20–1.78) 1.17 (0.42–3.16) 0.984
 Model 3 1.00 1.13 (0.43–2.91) 0.64 (0.21–1.92) 1.19 (0.44–3.21) 0.947
Low HDL-C
 Model 1 1.00 0.76 (0.27–2.14) 0.76 (0.29–2.01) 0.49 (0.16–1.49) 0.235
 Model 2 1.00 0.68 (0.23–1.99) 0.70 (0.26–1.86) 0.43 (0.14–1.36) 0.171
 Model 3 1.00 0.69 (0.23–2.02) 0.72 (0.27–1.92) 0.44 (0.14–1.39) 0.181
Abdominal obesity
 Model 1 1.00 1.54 (0.71–3.35) 0.75 (0.31–1.80) 1.32 (0.59–2.95) 0.899
 Model 2 1.00 1.53 (0.69–3.78) 0.72 (0.29–1.77) 1.15 (0.48–2.77) 0.854
 Model 3 1.00 2.31 (0.95–5.61) 0.88 (0.33–2.35) 1.26 (0.48–3.34) 0.865
Hypertension
 Model 1 1.00 1.72 (0.63–4.72) 1.48 (0.53–4.14) 1.10 (0.38–3.21) 0.990
 Model 2 1.00 1.86 (0.67–5.19) 1.65 (0.57–4.77) 1.18 (0.39–3.58) 0.878
 Model 3 1.00 2.00 (0.71–5.66) 1.91 (0.65–5.60) 1.28 (0.42–3.94) 0.748
High FPG
 Model 1 1.00 1.17 (0.46–2.97) 0.62 (0.22–1.79) 1.18 (0.46–3.06) 0.993
 Model 2 1.00 1.10 (0.43–2.82) 0.60 (0.20–1.78) 1.17 (0.44–3.16) 0.984
 Model 3 1.00 1.13 (0.44–2.91) 0.64 (0.21–1.92) 1.19 (0.44–3.21) 0.947
High TGs
 Model 1 1.00 0.62 (0.23–1.63) 0.49 (0.18–1.31) 0.79 (0.30–2.07) 0.464
 Model 2 1.00 0.60 (0.22–1.60) 0.43 (0.15–1.20) 0.77 (0.28–2.11) 0.419
 Model 3 1.00 0.64 (0.24–1.73) 0.47 (0.16–1.34) 0.84 (0.30–2.33) 0.544

MetS metabolic syndrome, HDL-C high density lipoprotein-cholesterol, FPG fasting plasma glucose, TGs triglycerides

Model1: Adjusted for baseline age, sex, total energy intake, physical activity, and family history of diabetes

Model 2: Additionally adjusted for dietary fiber, tea and coffee, red and processed meat, fruit, and vegetable

Model 3: Additionally adjusted for body mass index

1Based on logistic regression model using median intake of sugar sweetened beverages in each quartile as a continuous variable

Discussion

In the present study, we provided evidence that children and adolescents who consumed SSB over 90 ml/day (one third of a serving) had almost a 3-fold increased risk of incident MetS, abdominal obesity, and hypertension independent of confounders, particularly BMI. Similarly, higher SSSD consumption was directly associated with incidence of MetS, abdominal obesity, and hypertension.

Findings of the current study support those of prospective ones conducted on SSBs and MetS in adults [28, 29], which report that adults with higher SSB consumption had a 0.5–2 fold increased risk of incident MetS. To our knowledge, the present study is the first to examine the association of SSB, SSSD, and fruit juice drink consumption with MetS in longitudinal analysis in children and adolescents. Our findings are consistent with previously published cross-sectional reports in which high SSBs consumption was associated with prevalent MetS and higher insulin resistance in children and adolescents [13, 30, 31]. Adolescents, aged 12 to 16 years, with higher consumption of SSB had a 5.1-fold increased prevalence of MetS [13]. Also each additional SSB serving intake was associated with a 5 % increment of insulin resistance among 12–19 year-old American adolescents [31]. In addition, higher SSB consumption in children, aged 8–10 years, was associated with a 0.1-unit higher HOMA-IR [30]. Our prospective findings confirmed the proposed causal link in cross-sectional studies between SSB consumption, insulin resistance, and MetS.

Sugar sweetened carbonated soft drinks are among the components of SSB and in the current study, had a positive association with incident MetS, abdominal obesity, and hypertension. Similarly, these beverages are associated with greater odds of unfavorable changes in cardio-metabolic risk factors, independent of body weight [31, 32]. The Western Australian Cohort (Raine) Study showed that SSB consumption of over 1.3 servings/d, was associated with a 3.2-fold increment of overall cardio-metabolic risk, and had unfavorable effects on changes of waist circumference, TGs, and HDL-C, independent of BMI after a 2-year follow-up [32]. Our results are also consistent with a cross-sectional study of 12–19 year-old American adolescents, who consumed on average 7.4 servings of SSBs daily, indicating that each additional SSB serving intake was associated with increments of systolic blood pressure and waist circumference, and with decreased HDL-C, after adjusting for age, sex, race, menarche, and energy intake, but not for BMI [31]. Interestingly, our study found an approximately 3.6-fold greater risk of MetS following consumption of a one third of serving of SSSDs comparable to results of studies with similar cardio-metabolic risks [32] but with much higher consumption, highlighting the magnitude of this association in the current study.

Dietary behavior, socio-economic factors, and physiological effects explain the unfavorable effects of higher SSB consumption on metabolic abnormalities [29]; subjects with increased SSB consumption may show properties of unhealthy dietary pattern [33]. In the current study, individuals with higher SSB consumption had higher intakes of total energy, trans and saturated fatty acids, fructose, simple sugars, and glycemic load. Lower socioeconomic status and increased hours of watching TV were associated with increased SSB intake; children from low socioeconomic status areas consumed sugar sweetened soft drinks approximately twice as common [34]. In the current investigation, 35 % parents of children studied had education levels < 12 years, which is an important point to consider in interpretation of findings. Several studies highlight the potential for parents to influence SSB intakes of children and adolescents, possibly as they are the main purchasers of food and beverages consumed; those who have parents or caregivers with high education status consume lower amounts of SSBs compared to those who have parents with lower levels of education [32]. Because SSBs are in liquid form, they induce lower satiety and higher energy intake, compared to solid form of foods [10]. Fruit juice drinks in Iran include both natural and synthetic fruit juices with added sugars. Compared to SSSDs and fruit juice drinks, other sugar sweetened beverages such as beverages made with powdered flavoring, non-juice fruit-flavored drinks, sports drinks, artificial non-caloric carbonated soft drinks, or sweetened coffee drinks are far less frequently consumed in Iran, they were not considered in our analysis. Higher SSB consumption has indirect and direct associations with insulin resistance and MetS; the direct association is due to the glycemic effects of the large amounts of absorbed sugars or metabolic effects of fructose and the indirect association because of weight gain. Evidence indicates that higher SSB consumption is concomitant with excess body weight gain, which may lead to unhealthy metabolic homeostasis [35, 36]. In the current study, BMI rose according to the quartiles of SSB consumption; however, the associations between incident MetS and higher SSB intakes remained significant even after controlling for BMI, indicating that SSB may affect insulin resistance via pathways that do not include excess weight. The physiological effect of SSB consumption on metabolic abnormalities may be explained by high dietary glycemic load leading to a postprandial rise in blood glucose and insulin concentrations, which over time may lead to hyperinsulinemia and insulin resistance [37]. Also, an increase in glycemic load occurred simultaneously with exacerbated levels of inflammatory biomarkers such as interleukin-6, linked to insulin resistance [38]. Furthermore, the effects of fructose as the main constituent of additive nutritive sweeteners such as high fructose corn syrup and sucrose on metabolic profile are well defined in animal and human studies [39, 40]. High fructose diet increased lipogenesis, leptin resistance, intra-abdominal fat storage, hunger rating, energy intake, CRP concentration, blood pressure, and induced impaired fasting glucose by insulin resistance in the liver and adipose tissue [40, 41]. Fructose is preferentially metabolized to lipid in the liver leading to increased triglyceride levels, which have been associated with development of insulin resistance [42]. Moreover, fructose increased serum uric acid and enhanced reabsorption of salt and water in the small intestine and kidney, indicating the hypertension-induced effects of fructose [43].

Our study has both strengths and limitations. Some limitations of our analysis deserve comment; using an FFQ cannot estimate the ‘actual’ intake of participants. However, we used the FFQ to rank individuals based on their habitual intakes of SSBs. Also, the low-resolution capacity of FFQ that relays in memory of food consumption is critical at any age but, worst in children. However, for the children and adolescents, FFQ is an instrument, which can be administered in large populations and be accurate, reproducible, and relatively inexpensive for repeated measures. Several studies show that past dietary intake of children and adolescents can be measured reasonably well by FFQ [4446]. Using well-trained interviewers who are skilled in the art of asking questions that help subjects remember what they ate and asking mothers about the type and quantity of meals and snacks when children were unable to recall may help minimizing the memory limitations. Another limitation was the lack of data on puberty stage. In addition, the fruit juice drink item in the FFQ was not assessed separately for 100 % fruit juice and sugar sweetened synthetic juice drinks that are not 100 % juice. Furthermore, the SSSD item assessed in the FFQ did not differentiate between the artificial non-caloric sweeteners and those containing caloric sugar e.g. fructose or sucrose. As for strengths, despite the limitations, to our knowledge, this is the first study to evaluate SSB consumption in relation to incidence of MetS after a 3.6 year follow-up among children and adolescents. Longitudinal design of the study allowed us to confirm the role of SSB consumption on the incidence of MetS. Furthermore, collection of socio-demographic information of the population-based cohort subjects facilitated a thorough investigation of possible confounders.

Conclusion

Our results examining the prospective associations provide evidence that greater SSB consumption during childhood and adolescence may have undesirable effects on cardio-metabolic risk factors, some of which may be independent of BMI. The results suggest that SSB particularly SSSD consumption should be limited during early years to prevent future occurrence of MetS. Although SSBs are a disposable component of world’s modern diet, findings of the current study and those from systematic reviews on the contribution of SSBs on health provide strong evidence of harm. We should not wait for absolute proof and healthy alternatives to SSBs should be promoted.

Acknowledgment

This work was funded by a grant from the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. The authors express appreciation to the participants in the Tehran Lipid and Glucose Study for their enthusiastic support, and the staff of the Tehran Lipid and Glucose Study Unit of the Research Institute for Endocrine Sciences, for their valuable help. The authors wish to acknowledge Ms Niloofar Shiva for critical editing of English grammar and syntax of the manuscript.

Abbreviations

MetS

Metabolic syndrome

SSB

Sugar sweetened beverage

TLGS

Tehran Lipid and Glucose Study

TG

Triglyceride

HDL-C

High density lipoprotein cholesterol

FPG

Fasting plasma glucose

FFQ

Food frequency questionnaire

USDA

United States department of agriculture

SSSD

Ssugar sweetened carbonated soft drink

DR

Dietary recall

MAQ

Modifiable activity questionnaire

MET

Metabolic equivalent task

BMI

Body mass index

WC

Waist circumference

OR

Odds ratio

CI

Confidence interval

Footnotes

Competing interests

The authors declare that they have no competing of interests.

Authors’ contribution

The project was designed and implemented by P.M and G.A. Data were analyzed and interpreted by E.Y and S.H-N. P.M, E.Y, G.A and S.H-N prepared the manuscript. P.M and F.A supervised overall project. All authors read and approved the final version of manuscript.

Contributor Information

Parvin Mirmiran, Phone: +98 (21) 22432503, Email: mirmiran@endocrine.ac.ir, Email: parvin.mirmiran@gmail.com.

Emad Yuzbashian, Email: e_yuzbashian@endocrine.ac.ir.

Golaleh Asghari, Email: g_asghari@endocrine.ac.ir.

Somayeh Hosseinpour-Niazi, Email: s.hossainpour@endocrine.ac.ir.

Fereidoun Azizi, Email: azizi@endocrine.ac.ir.

References

  • 1.Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord. 2013;11:71–80. doi: 10.1089/met.2012.0122. [DOI] [PubMed] [Google Scholar]
  • 2.Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152:201–6. doi: 10.1016/j.jpeds.2007.09.010. [DOI] [PubMed] [Google Scholar]
  • 3.Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics. 2007;120:340–5. doi: 10.1542/peds.2006-1699. [DOI] [PubMed] [Google Scholar]
  • 4.Lusis AJ, Attie AD, Reue K. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet. 2008;9:819–30. doi: 10.1038/nrg2468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yudkin JS. Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology. Diabetologia. 2007;50:1576–86. doi: 10.1007/s00125-007-0711-3. [DOI] [PubMed] [Google Scholar]
  • 6.Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci. 2013;1281:123–40. doi: 10.1111/nyas.12030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Harrington S. The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature. J Sch Nurs. 2008;24:3–12. doi: 10.1177/10598405080240010201. [DOI] [PubMed] [Google Scholar]
  • 8.Overby NC, Lillegaard IT, Johansson L, Andersen LF. High intake of added sugar among Norwegian children and adolescents. Public Health Nutr. 2004;7:285–93. doi: 10.1079/PHN2003515. [DOI] [PubMed] [Google Scholar]
  • 9.Reedy J, Krebs-Smith SM. Dietary sources of energy, solid fats, and added sugars among children and adolescents in the United States. J Am Diet Assoc. 2010;110:1477–84. doi: 10.1016/j.jada.2010.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation. 2010;121:1356–64. doi: 10.1161/CIRCULATIONAHA.109.876185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:1084–102. doi: 10.3945/ajcn.113.058362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Althuis MD, Weed DL. Evidence mapping: methodologic foundations and application to intervention and observational research on sugar-sweetened beverages and health outcomes. Am J Clin Nutr. 2013;98:755–68. doi: 10.3945/ajcn.113.058917. [DOI] [PubMed] [Google Scholar]
  • 13.Chan TF, Lin WT, Huang HL, Lee CY, Wu PW, Chiu YW, et al. Consumption of sugar-sweetened beverages is associated with components of the metabolic syndrome in adolescents. Nutrients. 2014;6:2088–103. doi: 10.3390/nu6052088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5. doi: 10.1186/1745-6215-10-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Asghari G, Mirmiran P, Rashidkhani B, Asghari-Jafarabadi M, Mehran M, Azizi F. The association between diet quality indices and obesity: Tehran Lipid and Glucose Study. Arch Iran Med. 2012;15:599–605. [PubMed] [Google Scholar]
  • 16.Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13:654–62. doi: 10.1017/S1368980009991698. [DOI] [PubMed] [Google Scholar]
  • 17.Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 2010;20:150–8. doi: 10.2188/jea.JE20090083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 2012;108:1109–17. doi: 10.1017/S0007114511006313. [DOI] [PubMed] [Google Scholar]
  • 19.Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of food. Tehran: Keshaverzi press; 1999. [Google Scholar]
  • 20.Kriska AM, Edelstein SL, Hamman RF, Otto A, Bray GA, Mayer-Davis EJ, et al. Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. Med Sci Sports Exerc. 2006;38:826–32. doi: 10.1249/01.mss.0000218138.91812.f9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Delshad M, Ghanbarian A, Ghaleh NR, Amirshekari G, Askari S, Azizi F. Reliability and validity of the modifiable activity questionnaire for an Iranian urban adolescent population. Int J Prev Med. 2015;6:3. doi: 10.4103/2008-7802.151433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157:821–7. doi: 10.1001/archpedi.157.8.821. [DOI] [PubMed] [Google Scholar]
  • 23.Kelishadi R, Gouya MM, Ardalan G, Hosseini M, Motaghian M, Delavari A, et al. First reference curves of waist and hip circumferences in an Asian population of youths: CASPIAN study. J Trop Pediatr. 2007;53:158–64. doi: 10.1093/tropej/fml090. [DOI] [PubMed] [Google Scholar]
  • 24.National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and adolescent The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576. doi: 10.1542/peds.114.2.S2.555. [DOI] [PubMed] [Google Scholar]
  • 25.Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7. doi: 10.2337/diacare.26.12.3331. [DOI] [PubMed] [Google Scholar]
  • 26.Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5. doi: 10.1161/CIRCULATIONAHA.109.192644. [DOI] [PubMed] [Google Scholar]
  • 27.Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32:1092–7. doi: 10.2337/dc08-1800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Barrio-Lopez MT, Martinez-Gonzalez MA, Fernandez-Montero A, Beunza JJ, Zazpe I, Bes-Rastrollo M. Prospective study of changes in sugar-sweetened beverage consumption and the incidence of the metabolic syndrome and its components: the SUN cohort. Br J Nutr. 2013;110:1722–31. doi: 10.1017/S0007114513000822. [DOI] [PubMed] [Google Scholar]
  • 29.Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007;116:480–8. doi: 10.1161/CIRCULATIONAHA.107.689935. [DOI] [PubMed] [Google Scholar]
  • 30.Wang JW, Mark S, Henderson M, O’Loughlin J, Tremblay A, Wortman J, et al. Adiposity and glucose intolerance exacerbate components of metabolic syndrome in children consuming sugar-sweetened beverages: QUALITY cohort study. Pediatr Obes. 2013;8:284–93. doi: 10.1111/j.2047-6310.2012.00108.x. [DOI] [PubMed] [Google Scholar]
  • 31.Bremer AA, Auinger P, Byrd RS. Relationship between insulin resistance-associated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US adolescents: findings from the 1999–2004 National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med. 2009;163:328–335. doi: 10.1001/archpediatrics.2009.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ambrosini GL, Oddy WH, Huang RC, Mori TA, Beilin LJ, Jebb SA. Prospective associations between sugar-sweetened beverage intakes and cardiometabolic risk factors in adolescents. Am J Clin Nutr. 2013;98:327–34. doi: 10.3945/ajcn.112.051383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Shang L, O’Loughlin J, Tremblay A, Gray-Donald K. The association between food patterns and adiposity among Canadian children at risk of overweight. Appl Physiol Nutr Metab. 2014;39:195–201. doi: 10.1139/apnm-2012-0392. [DOI] [PubMed] [Google Scholar]
  • 34.Clifton PM, Chan L, Moss CL, Miller MD, Cobiac L. Beverage intake and obesity in Australian children. Nutr Metab (Lond) 2011;8:87. doi: 10.1186/1743-7075-8-87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar. Diabetes Care. 2014;37:950–6. doi: 10.2337/dc13-2085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wang J. Consumption of added sugars and development of metabolic syndrome components among a sample of youth at risk of obesity. Appl Physiol Nutr Metab. 2014;39:512. doi: 10.1139/apnm-2013-0456. [DOI] [Google Scholar]
  • 37.Dominguez Coello S, Cabrera De Leon A, Rodriguez Perez MC, Borges Alamo C, Carrillo Fernandez L, Almeida Gonzalez D, et al. Association between glycemic index, glycemic load, and fructose with insulin resistance: the CDC of the Canary Islands study. Eur J Nutr. 2010;49:505–512. doi: 10.1007/s00394-010-0110-2. [DOI] [PubMed] [Google Scholar]
  • 38.Goletzke J, Buyken AE, Joslowski G, Bolzenius K, Remer T, Carstensen M, et al. Increased intake of carbohydrates from sources with a higher glycemic index and lower consumption of whole grains during puberty are prospectively associated with higher IL-6 concentrations in younger adulthood among healthy individuals. J Nutr. 2014;144:1586–93. doi: 10.3945/jn.114.193391. [DOI] [PubMed] [Google Scholar]
  • 39.Kelishadi R, Mansourian M, Heidari-Beni M. Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. Nutrition. 2014;30:503–10. doi: 10.1016/j.nut.2013.08.014. [DOI] [PubMed] [Google Scholar]
  • 40.Stanhope KL, Schwarz JM, Havel PJ. Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies. Curr Opin Lipidol. 2013;24:198–206. doi: 10.1097/MOL.0b013e3283613bca. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hosseini-Esfahani F, Bahadoran Z, Mirmiran P, Hosseinpour-Niazi S, Hosseinpanah F, Azizi F. Dietary fructose and risk of metabolic syndrome in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond) 2011;8:50. doi: 10.1186/1743-7075-8-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005;2:5. doi: 10.1186/1743-7075-2-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bobridge KS, Haines GL, Mori TA, Beilin LJ, Oddy WH, Sherriff J, et al. Dietary fructose in relation to blood pressure and serum uric acid in adolescent boys and girls. J Hum Hypertens. 2013;27:217–24. doi: 10.1038/jhh.2012.36. [DOI] [PubMed] [Google Scholar]
  • 44.Eck LH, Klesges RC, Hanson CL, Slawson D, Portis L, Lavasque ME. Measuring short-term dietary intake: development and testing of a 1-week food frequency questionnaire. J Am Diet Assoc. 1991;91:940–5. [PubMed] [Google Scholar]
  • 45.Blom L, Lundmark K, Dahlquist G, Persson LA. Estimating children’s eating habits. Validity of a questionnaire measuring food frequency compared to a 7-day record. Acta Paediatr Scand. 1989;78:858–864. doi: 10.1111/j.1651-2227.1989.tb11164.x. [DOI] [PubMed] [Google Scholar]
  • 46.Frank GC, Nicklas TA, Webber LS, Major C, Miller JF, Berenson GS. A food frequency questionnaire for adolescents: defining eating patterns. J Am Diet Assoc. 1992;92:313–8. [PubMed] [Google Scholar]

Articles from Nutrition & Metabolism are provided here courtesy of BMC

RESOURCES